Table 3. Demographics, clinical characteristics during acute admission, and cycle threshold of preliminary clinic group in study of severe neurologic sequelae among Ebola virus disease survivors, by those who had severe and those who had no severe neurologic conditions, Sierre Leone*.
| Characteristic | No severe neurologic features, n = 21 | Severe neurologic features, n = 19 | Crude odds ratio† (95% CI) |
|---|---|---|---|
| Age, y, median (IQR) | 28 (23–60) | 32 (25–42) | 0.01 (0.00–0.036)/y |
| Female sex, % (95% CI) | 48 (43–54) | 68 43–87 | 2.3 (0.79–7.60) |
| Length of stay, d, median (IQR) | 18 (14–28) | 25 (13–29) | 0.02/d |
| Seizures during admission, % (95% CI) | 19 (5–42) | 21 (6–46) | 1.13 (0.18–7.23) |
| Unconscious during admission, % (95% CI) | 33 (15–57) | 63 (38–83) | 3.32 (0.79–15.4) |
| Bleeding during admission, % (95% CI) | 19 (5–42) | 5 (0.1–26) | 0.24 (0.00–2.80) |
| Cycle threshold, median (IQR) | 22.8 (22.1–24.1), n = 9 | 27.2 (22.5–30.1), n = 10 | 0.22 (0.7–1.3) for each increment |
*Severe conditions were those requiring specialist referral. †Odds ratio of patients having severe neurologic features compared with those who did not.